Shares of Corbus Pharmaceuticals Holdings Inc. CRBP were unchanged Monday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.06% to 12,198.74 and Dow Jones Industrial Average DJIA falling 0.91% to 29,638.64. Corbus Pharmaceuticals Holdings Inc. closed $8.56 short of its 52-week high ($9.78), which the company reached on August 31st.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Fate Therapeutics Inc. FATE rose 0.94% to $58.47, Vanda Pharmaceuticals Inc. VNDA fell 1.61% to $12.21, and Viking Therapeutics Inc. VKTX fell 3.74% to $6.43. Trading volume (5.1 M) eclipsed its 50-day average volume of 4.3 M.